Out-of-pocket costs rising for patients

Out-of-pocket healthcare costs rose about 12% in 2018, according to a new TransUnion Healthcare analysis. Costs increased for patients across all settings over care from 2017 to 2018, underscoring that Americans may be feeling the pinch.

During a healthcare visit, patients in 2018 had average out-of-pocket expenses between $501 and $1,000––a 39% jump from 2017 costs. Furthermore, those that had costs of $500 or less out of pocket declined from 49% of patients in 2017 to 36% in 2018. Fortunately, only 5% of patients had costs above $1,000, compared to 12% in 2017.

“For several years patients have faced a greater cost burden as healthcare expenses shifted from payers to patients,” Dave Wojczynski, president of TransUnion Healthcare, said in a statement. “As a result, patients are now making decisions about where they receive care based on costs – not just the quality of care they may receive. This means price transparency is critical for healthcare providers who are not only competing for patients, but also want to secure timely payments from them.”

As healthcare costs rise across the industry, patients are being pushed into more outpatient settings, which are typically lower than inpatient settings.

“Patients are likely seeing more providers and payers recommending that they take advantage of cost-effective healthcare options, which brings down costs for all parties,” Jonathan Wiik, principal of healthcare strategy at TransUnion Healthcare, said in a statement. “This is especially important as costs continue to rise in all areas of healthcare, particularly in inpatient, outpatient and emergency department services.”

However, it’s still hard for patients to pay their bills, with about a third of patients having trouble paying their deductible before insurance will pay for care.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.